CIK 0001740279
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
IN8BIO, INC.
Sign in to watch- Ticker
- INAB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825462585
- Phone
- +1 646-600-6438
- Business address
- EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
- Former names
- Incysus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-03 | FAIRBAIRN EMILY Director | Conversion · Series A Preferred Stock | −2,930,332 | 0 | ||
| 2021-07-29 | Whitfill Travis Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2021-07-29 | Roemer Alan S. Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2021-07-29 | McCall Patrick Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2021-07-29 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +61,500 | 61,500 | ||
| 2021-07-29 | Ho William Tai-Wei President, CEO and CFO | Grant or award · Employee Stock Option (right to buy) | +220,500 | 220,500 | ||
| 2021-07-29 | Greenwood Luba Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2021-07-29 | FAIRBAIRN EMILY Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2021-07-29 | Brandt Peter C. Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 |
Page 16 of 16 · 309 trades